Anti-Human ERFE Antibody (SAA2375) from ProteoGenix; catalogue ARO-A22784; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing the Anti-Human ERFE Antibody (SAA2375), a powerful tool for biotech research. This highly specific antibody targets the erythroferrone (ERFE) protein, which plays a crucial role in regulating iron metabolism in the human body.
The ERFE protein is secreted by the liver in response to anemia or increased erythropoietin levels. It acts as a negative regulator of iron absorption, reducing the amount of iron absorbed from the diet and stored in the body. This function is essential for maintaining iron homeostasis and preventing iron overload, which can lead to serious health issues.
The Anti-Human ERFE Antibody is a valuable tool for studying iron metabolism and its role in various diseases. It is particularly useful in research related to anemia, iron deficiency, and iron overload disorders. This antibody can also aid in the development of new treatments for these conditions.
The Anti-Human ERFE Antibody has been extensively used in various experimental studies. In one study, it was used to investigate the role of ERFE in iron metabolism and anemia associated with chronic kidney disease. Another study utilized this antibody to examine the effects of ERFE on iron absorption and utilization in pregnant women. These are just a few examples of the numerous research applications of this antibody.
With its high specificity and sensitivity, the Anti-Human ERFE Antibody (SAA2375) is a reliable tool for accurate and reproducible results in biotech research. Its use can lead to a better understanding of iron metabolism and its implications in various diseases, ultimately aiding in the development of effective treatments.
In summary, the Anti-Human ERFE Antibody is a valuable asset for any biotech researcher studying iron metabolism. Its ability to specifically target the ERFE protein makes it a powerful tool for understanding the complexities of iron regulation in the human body. Don’t miss out on the opportunity to enhance your research with this cutting-edge antibody. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A22784. For research use only.
Target: Erythroferrone, Complement C1q tumor necrosis factor-related protein 15, Myonectin, ERFE, C1QTNF15, CTRP15, FAM132B; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
